Taro Pharmaceutical Industries

-1.45 (-1.94%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.81B
Current PEN/A
Forward PE 18.67
2yr Forward PE 16.34
See more stats
Estimates Current Quarter
Revenue$137.2 Million
Adjusted EPS$0.84
See more estimates
10-Day MA$74.07
50-Day MA$73.56
200-Day MA$69.74
See more pivots

Taro Pharmaceutical Industries Stock, NYSE:TARO

14 Hakitor Street, 14 Hakitor Street, Haifa Bay, Haifa 2624761
Phone: +972.4.847.5700
Number of Employees: 1464


Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.